Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2016, inter alia, approved the following items and recommended to the members for their approval in the ensuing Annual General Meeting:
1. Granting of 1,75,000 Employee Stock options (NATSOP2016) to the eligible employees of the Company.
2. Increase of remuneration to Working Directors.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
